Seegene (096530 KQ/Buy)Second Consecutive Earnings Surprise
For 2Q26, Seegene posted revenue of W136bn (+19% YoY), beating the consensus and marking a new quarterly record. This also marked the ninth...
93 Views
Seegene (C KQ/Buy) Annual OP Margin to Return to Double Digits for the First Time in Four Years
For 1Q26, Seegene reported revenue of W129.1bn (+11% YoY), in line with the consensus, and operating profit of W23.6bn (+59% YoY; OP margin of...
114 Views
Seegene (096530 KQ/Buy)In-Vitro Diagnostic Revenue of W500bn Within Reach
In-vitro diagnostic revenue of W500bn within reach4Q25 review: Revenue meets consensus; OP misses For 4Q25, Seegene posted revenue of W130
144 Views
Seegene (096530 KQ/Buy)Margins Appear to Have Bottomed; 2H Outlook Remains Encouraging
For 2Q25, Seegene posted revenue of W114.1bn (+14% YoY), broadly in line with the consensus. HPV (+21% YoY) and gastrointestinal (+31% YoY) test...
430 Views